Sfoglia per Autore
Idiotypic reactive T cells
1998-01-01 Massaia, Massimo*; Mariani, Sara; Battaglio, Silvano; Beggiato, Eloise; Besostri, Barbara; Borrione, Paolo; Coscia, Marta; Napoli, Patrizia; Peola, Silvia; Bianchi, Alberto; Boccadoro, Mario; Pileri, Alessandro
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy.
1999-01-01 MASSAIA M; BORRIONE P; BATTAGLIO S; MARIANI S; BEGGIATO E; NAPOLI P; VOENA C; BIANCHI A; COSCIA M; BESOSTRI B; PEOLA S; EVEN J; NOVERO D; M. BOCCADORO; PILERI A
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.
2000-01-01 BESOSTRI B ;BEGGIATO E ;BIANCHI A ;MARIANI S ;COSCIA M ;PEOLA S ;FOGLIETTA M ;BOCCADORO M ;PILERI A ;MORETTA L ;MASSAIA M
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion.
2001-01-01 MARIANI S; COSCIA M; EVEN J; PEOLA S; FOGLIETTA M; M. BOCCADORO; SBAIZ L; RESTAGNO G; PILERI A; MASSAIA M.
Myeloma cells drive the maturation of dendritic cells versus a Th2-promoting phenotype which impairs T-cell activation.
2003-01-01 Fiore F; Nushack B; Peola S; Coscia M; Folgietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massaia M
MYELOMA CELLS DRIVE THE MATURATION OF DENDRITIC CELLS VERSUS A TH2-PROMOTING PHENOTYPE WHICH IMPAIRS T-CELL ACTIVATION
2004-01-01 Fiore F; Nushack B; Peola S; Coscia M; Foglietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massimo M
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy
2004-01-01 COSCIA M; MARIANI S; BATTAGLIO S; DI BELLO C; FIORE F; FOGLIETTA M; PILERI A; BOCCADORO M; MASSAIA M
Therapeutic idiotype vaccines in B lymphoproliferative diseases
2004-01-01 COSCIA M ;KWAK LW
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis
2004-01-01 RUFFINI PA; BIRAGYN A; COSCIA M; HARVEY LK; CHA SC; BOGEN B; KWAK LW
NEW PROSPECTS FOR INDUCTION OF ANTI-LYMPHOMA IMMUNITY USING DNA VACCINES EXPRESSING CHEMOKINE-PARTICLES
2004-01-01 Coscia M; Ruffini P; Neelapu S; Kwak LA; Biragyn A.
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
2004-01-01 A. BIRAGYN; P.A. RUFFINI; M. COSCIA; L.K. HARVEY; S.S. NEELAPU; S. BASKAR; J.M. WANG; L.W. KWAK
Cancer immunotherapy with chemoattractant peptides
2004-01-01 M. COSCIA; A. BIRAGYN
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
2005-01-01 Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells
2005-01-01 F. FIORE; B. NUSCHAK; S. PEOLA; S. MARIANI; M. MURARO; M. FOGLIETTA; M. COSCIA; B. BRUNO; M. BOCCADORO; M. MASSAIA
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions
2006-01-01 Myriam Foglietta; Sara Mariani; Barbara Castella; Marta Coscia; Laura Godio; Serena Zappia; Mario Boccadoro; Massimo Massaia
Zoledronic acid impairs mammary carcinogenesis in BALB/c mice transgenic for the Her-2/neu oncogene.
2006-01-01 Coscia M; Quaglino E; Curcio C; Pantaleoni F; Forni G; Massaia M.
Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells
2006-01-01 Francesca Fiore; Barbara Castella; Barbara Nuschak; Raffaello Bertieri; Sara Mariani; Serena Zappia; Marta Coscia; Mario Boccadoro; Massimo Massaia
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene
2006-01-01 Coscia M; Quaglino E; Pantaleoni F; Curcio C; Boccadoro M; Forni G; Massaia M
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma
2006-01-01 Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Idiotypic reactive T cells | 1998 | Massaia, Massimo*; Mariani, Sara; Battaglio, Silvano; Beggiato, Eloise; Besostri, Barbara; Borrione, Paolo; Coscia, Marta; Napoli, Patrizia; Peola, Silvia; Bianchi, Alberto; Boccadoro, Mario; Pileri, Alessandro | |
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. | 1999 | MASSAIA M; BORRIONE P; BATTAGLIO S; MARIANI S; BEGGIATO E; NAPOLI P; VOENA C; BIANCHI A; COSCIA M; BESOSTRI B; PEOLA S; EVEN J; NOVERO D; M. BOCCADORO; PILERI A | |
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients. | 2000 | BESOSTRI B ;BEGGIATO E ;BIANCHI A ;MARIANI S ;COSCIA M ;PEOLA S ;FOGLIETTA M ;BOCCADORO M ;PILERI A ;MORETTA L ;MASSAIA M | |
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. | 2001 | MARIANI S; COSCIA M; EVEN J; PEOLA S; FOGLIETTA M; M. BOCCADORO; SBAIZ L; RESTAGNO G; PILERI A; MASSAIA M. | |
Myeloma cells drive the maturation of dendritic cells versus a Th2-promoting phenotype which impairs T-cell activation. | 2003 | Fiore F; Nushack B; Peola S; Coscia M; Folgietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massaia M | |
MYELOMA CELLS DRIVE THE MATURATION OF DENDRITIC CELLS VERSUS A TH2-PROMOTING PHENOTYPE WHICH IMPAIRS T-CELL ACTIVATION | 2004 | Fiore F; Nushack B; Peola S; Coscia M; Foglietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massimo M | |
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 2004 | Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M | |
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy | 2004 | COSCIA M; MARIANI S; BATTAGLIO S; DI BELLO C; FIORE F; FOGLIETTA M; PILERI A; BOCCADORO M; MASSAIA M | |
Therapeutic idiotype vaccines in B lymphoproliferative diseases | 2004 | COSCIA M ;KWAK LW | |
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis | 2004 | RUFFINI PA; BIRAGYN A; COSCIA M; HARVEY LK; CHA SC; BOGEN B; KWAK LW | |
NEW PROSPECTS FOR INDUCTION OF ANTI-LYMPHOMA IMMUNITY USING DNA VACCINES EXPRESSING CHEMOKINE-PARTICLES | 2004 | Coscia M; Ruffini P; Neelapu S; Kwak LA; Biragyn A. | |
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo | 2004 | A. BIRAGYN; P.A. RUFFINI; M. COSCIA; L.K. HARVEY; S.S. NEELAPU; S. BASKAR; J.M. WANG; L.W. KWAK | |
Cancer immunotherapy with chemoattractant peptides | 2004 | M. COSCIA; A. BIRAGYN | |
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma | 2005 | Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M | |
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells | 2005 | F. FIORE; B. NUSCHAK; S. PEOLA; S. MARIANI; M. MURARO; M. FOGLIETTA; M. COSCIA; B. BRUNO; M. BOCCADORO; M. MASSAIA | |
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions | 2006 | Myriam Foglietta; Sara Mariani; Barbara Castella; Marta Coscia; Laura Godio; Serena Zappia; Mario Boccadoro; Massimo Massaia | |
Zoledronic acid impairs mammary carcinogenesis in BALB/c mice transgenic for the Her-2/neu oncogene. | 2006 | Coscia M; Quaglino E; Curcio C; Pantaleoni F; Forni G; Massaia M. | |
Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells | 2006 | Francesca Fiore; Barbara Castella; Barbara Nuschak; Raffaello Bertieri; Sara Mariani; Serena Zappia; Marta Coscia; Mario Boccadoro; Massimo Massaia | |
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene | 2006 | Coscia M; Quaglino E; Pantaleoni F; Curcio C; Boccadoro M; Forni G; Massaia M | |
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma | 2006 | Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile